Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Merck & Co. Inc. (MRK)’

stock, market, buy, graph, risk, trading, dice, concepts, chart, objects, investment, opportunity, business, three-dimensional, horizontal, line, gambling, decisions, symbol,

Hedge Fund and Insider Trading News: Steve Cohen, Starboard Value LP, Restaurant Brands International Inc (QSR), Graco Inc. (GGG), and More

Steve Cohen’s Venture Firm Invests in U.S. Cybersecurity Company (Reuters) NEW YORK (Reuters) – Billionaire investor Steve Cohen’s Point72......(read more)

February 20 - Hedge Funds, Insider Trading - Comments

Third Point 2014 Q3 Investor Letter

3 Stocks Billionaire Dan Loeb Bought in Q3 (and 2 He Dumped)

Billionaire Dan Loeb, the founder of $18 billion hedge fund Third Point, is mired in a fourth-straight year of trailing the market, though the activist......(read more)

December 20 - Hedge Fund Analysis, Hedge Funds, News - Comments

Ken Fisher FISHER ASSET MANAGEMENT

Billionaire Ken Fisher is Bullish About These Dividend Stocks

Fisher Investments was founded in 1979 by billionaire Ken Fisher. The fee-only investment adviser managed more than $100 billion in assets as of July......(read more)

November 13 - Dividend Stocks, Hedge Funds, News - Comments

Hedge Fund and Insider Trading News: Tom Steyer, Edward Lampert, Merck & Co., Inc. (MRK), Fiserv Inc (FISV), Alteryx Inc (AYX), and More

Billionaire’s Trump Impeachment Push Grows in Midterm Run-Up (Fox News) Liberal billionaire Tom Steyer claims to be building a juggernaut political......(read more)

October 19 - Hedge Funds, Insider Trading - Comments

Insider Trading Wall Street Trader Panic

Hedge Fund and Insider Trading News: Andreas Halvorsen, Bill Ackman, Paulson & Co., Merck & Co., Inc. (MRK), Arvinas Inc (ARVN), Y-mAbs Therapeutics (YMAB), and More

Andreas Halvorsen Discloses Stake In Urovant Sciences (Forbes.com) Andreas Halvorsen’s Viking Global Investors disclosed Thursday that it holds a 75......(read more)

October 12 - Hedge Funds, Insider Trading - Comments

Insider Buying Roundup: Elon Musk Buys Tesla (TSLA) Shares After Earnings Call Backlash

Tesla Motors Inc (NASDAQ:TSLA) CEO Elon Musk has made amends with investors of his company after a poorly handled earnings call last week sent shares......(read more)

May 8 - Insider Trading, News, Tech - Comments

stock, exchange, trade, ipo, market, london, share, rate, sales, price, new, york, profit, index, broker, chart, rising, falling, street, frankfurt, wall, world, cash, points, display,

Market Movers Today: Merck & Co., Inc. (MRK), Under Armour Inc (UA), General Electric Company (GE), and More

Merck & Co., Inc. (NYSE:MRK) (Ticker.tv) On Tuesday before the market opened, shares of Merck & Co ($MRK) were gapping up on news of positive......(read more)

January 16 - Market Movers, News - Comments

Biopharmaceutical, Bio-technology

Opus Point Partners’ AUM, History and Investments

Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr. Rosenwald......(read more)

August 25 - Hedge Funds, News - Comments

15 Biggest Healthcare Companies in USA

If you’re seeking to invest in stocks with great long-term potential and are interested in adding some exposure to the healthcare sector, then the......(read more)

July 6 - News - Comments

17 Countries With Universal Health Care in 2017

Should You Follow Hedge Funds Into These Healthcare Stocks?

Healthcare is a vast sector that nonetheless has huge growth prospects, with the U.S government and its citizens spending about $3 trillion annually......(read more)

May 3 - Hedge Funds, News - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Merck & Co. Inc. (MRK) Opens in Green Amid FDA Rejection Related to Diabetes Drugs

Merck & Co. Inc. (NYSE:MRK) entered the markets on April 7 in green, amid a thumbs down from the U.S. Food and Drug Administration on its request......(read more)

April 7 - News - Comments

Merck & Co., Inc. (MRK) Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug

Reports indicate that there are a number of plaintiffs filing lawsuits against Merck & Co., Inc. (NYSE:MRK) claiming that its shingles vaccine, Zostavax......(read more)

March 16 - News, Stock Analysis - Comments

FDA Endorses 3 New Drug Applications (NDAs) From Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)

The U.S. Food and Drug Administration (FDA) has acknowledged the filing for review of three New Drug Applications (NDAs) from Merck & Co., Inc. (NYSE......(read more)

March 8 - News, Stock Analysis - Comments

Merck & Co., Inc. (MRK) In $2.9 Billion Writedown After Market For Hepatitis C Drug Market Shrinks

Merck & Co., Inc. (NYSE:MRK) has announced that it will be writing down approximately $2.9 billion following the shrinking of the market for a hepatitis......(read more)

February 24 - News, Stock Analysis - Comments

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Why President Trump Wants To Transform The FDA – And What It Could Mean For Biotech Stocks

By Khojinur Usmonov From low costs to expedited drug approval, President Trump recently met with big pharma CEOs about overhauling the entire system.......(read more)

February 23 - News, Stock Analysis - Comments

Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK), And Other Pharmaceutical Firms All Targeting I-O Segment

Reports indicate that the market for immuno-oncology drugs could grow to $25 billion in the next ten years. Pharmaceutical firms such as Bristol-Myers......(read more)

February 21 - News, Stock Analysis - Comments

The FDA Accepts Keytruda From Merck & Co., Inc. (MRK) For Bladder Cancer

Patients with bladder cancer now having something to smile about, after the acceptance of 2 new supplemental biologics license applications, by the FDA......(read more)

February 7 - News, Stock Analysis - Comments

The European Medicines Agency (EMA) Recommends KEYTRUDA From Merck & Co., Inc. (MRK)

The European Commission has approved KEYTRUDA® (pembrolizumab), an anti-PD-1 therapy from Merck & Co., Inc. (NYSE:MRK). The Committee for Medicinal......(read more)

February 1 - News, Stock Analysis - Comments

trump, donald, 2014, d.c., politics, washington, politician, political, conservative, conference, cpac, republican, action

Pharmaceutical Executives From Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ) Met Trump

United States President Donald Trump is urging US drugmakers to consider manufacturing more of their drugs in the United States, thinking that higher......(read more)

February 1 - News, Stock Analysis - Comments

Merck & Co., Inc. (MRK) Is Among Many Drugmakers Being Criticized For Price Hikes

Merck & Co., Inc. (NYSE:MRK) is one of the pharma industry titans that are currently on the receiving end as a result of exaggerated drug price hikes......(read more)

January 30 - News, Stock Analysis - Comments

biotech research company, bio-technology companies

Bristol-Myers Squibb Co (BMY) To Share In Sales Of Merck & Co., Inc. (MRK) Keytruda Following Litigation Settlement

Merck & Co., Inc. (NYSE:MRK) has agreed to share a portion of Keytruda sales with Bristol-Myers Squibb Co (NYSE:BMY) and Ono Pharmaceutical Co., Ltd......(read more)

January 24 - News, Stock Analysis - Comments

Merck & Co., Inc. (MRK) And Palantir Technologies Inc Agree On Cancer Data Analysis Pact

Palantir Technologies Inc and Merck & Co., Inc. (NYSE:MRK) German parent Merck KGaA have entered into a deal that will see them work together on a......(read more)

January 18 - News, Stock Analysis - Comments

abdomen, asian, batten, belly, big, body, boy, cellulite, check, child, children, concept, diabetes, diet, excess, fat, hand, health, healthy, heart, kid, kids, lung, male, obese, obesity, overweight, pressure, stethoscope, stomach, thick, unhealthy, weight, young

11 Fattest Countries in The World

The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and......(read more)

January 17 - Lists, News - Comments

Merck & Co., Inc. (MRK) Joins Forces With M2Gen To Explore The ORIEN Avatar Research Program

Merck & Co., Inc. (NYSE:MRK), which is popularly known as MSD outside the United States and Canada, has become part of the Oncology Research Information......(read more)

January 6 - News, Stock Analysis - Comments

DUQUESNE CAPITAL

Billionaire Druckenmiller’s Top Dividend Stock Picks

Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros. Ranked 128th on Forbes’ list of the richest people......(read more)

December 23 - Dividend Stocks, Hedge Funds, News - Comments

Merck & Co., Inc. (MRK) Gets Coveted Approval For Keytruda

Individual lung cancer patients may soon be able to benefit from Keytruda, an immunotherapy drug from Merck & Co., Inc. (NYSE:MRK). The news comes......(read more)

December 2 - News, Stock Analysis - Comments

stock market, new york, wall street, banking, trade

Five Dow Jones Stocks That Can Outperform The Market

The Dow Jones Industrial Average (DJIA) comprises of 30 companies representing a diverse collection of stocks from all market sectors. These large cap......(read more)

November 30 - Hedge Funds, News - Comments

DUQUESNE CAPITAL

Bullish On Trump-led America, Druckenmiller Sells Gold, Bets On Economy

Stanley Druckenmiller is an American hedge fund manager who ran the $12 billion Duquesne Capital till 2010. Forbes has ranked him 128 on the list of the......(read more)

November 21 - Hedge Funds, News - Comments

Here’s What The OpGen Inc (OPGN) Merck & Co., Inc. (MRK) Agreement Really Means, And Why It’s So Important

OpGen Inc (NASDAQ:OPGN), a Market Exclusive favorite, earlier this week announced that it is bolstering its already long-standing relationship with pharmaceutical......(read more)

November 17 - News, Stock Analysis - Comments

Apple Inc. (AAPL), Alphabet Inc (GOOGL), More: See What This $36 Billion Hedge Fund Was Buying in Q3

Adage Capital Management is a Boston-based hedge fund founded in 2001 by Phil Gross and Robert Atchinson. As of June 30, Adage’s public equity portfolio......(read more)

November 15 - Hedge Fund Analysis, Hedge Funds, News - Comments

5 Healthcare Stocks Kahn Brothers Is Bullish On

Kahn Brothers is a New York-based hedge fund which was founded by famous American businessman Irving Kahn (who recently passed away at the age of 109......(read more)

November 8 - Hedge Fund Analysis, Hedge Funds, News - Comments

FDA Approves Merck & Co., Inc. (MRK) Keytruda For NSCLC

The US Food and Drug Administration (FDA) has recently approved the anti-programmed-death-receptor-1 (anti-PD-1) therapy of Merck & Co., Inc. (NYSE......(read more)

October 26 - News, Stock Analysis - Comments

Merck & Co. Inc. (MRK) Shuts Down Florida Facility

Merck & Co., Inc. (NYSE:MRK) will start laying off more than 100 employees in its production plant in Florida next month as it prepares for the closure......(read more)

October 6 - News, Stock Analysis - Comments

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

Inside the FDA Ebola Edition: Frontrunners Merck & Co., Inc. (MRK), GlaxoSmithKline PLC (ADR) (GSK)

Introduction Back on May 12, 2015, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee released a briefing......(read more)

August 29 - News, Stock Analysis - Comments

JP Morgan Chase JPM Office

Bourgeon Capital Management Reveals Top Picks for Q3, With JPMorgan Chase & Co. (JPM) Leading the Pack

Bourgeon Capital Management LLC, founded by John A. Zaro in 1999, operates as a boutique investment counseling firm that aims to serve high net-worth......(read more)

August 3 - Hedge Fund Analysis, Hedge Funds, News - Comments

Etsy, EA, and Avis (CAR) Among 5 Stocks Trending Early Wednesday

The U.S. dollar is stronger in early Wednesday activity as traders look forward to today’s release of the domestic employment report. With the......(read more)

August 3 - Earnings Report, Market Movers, News - Comments

stock market, new york, wall street, banking, trade

Trending Stocks: Xerox, LyondellBasell, Enbridge, and 2 More

U.S. stock futures are flat this morning following a decline in crude prices over worries surrounding renewed oversupply. Investors are also digging into......(read more)

July 29 - Earnings Report, Market Movers, News - Comments

mri, doctor, physicians, display, treatment, idea, medic, experiment, pharmaceutical, patient, future, interface, laboratory, multimedia, intelligence, male, digital, scan,

Market Exclusive’s Inside the FDA: This Week Bezlotoxumab from Merck & Co., Inc. (MRK)

On July 23, the Food and Drug Administration will make its decision on bezlotoxumab, brand name Zinplava, a Merck & Co., Inc. (NYSE:MRK) monoclonal......(read more)

July 22 - News, Stock Analysis - Comments

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, internet, male, drugstore, service,

Merck & Co., Inc. (MRK) and OpGen Inc (OPGN) Are Quietly Changing The Infectious Disease Landscape

Imagine the following scenario. A patient walks into a hospital with an infectious disease. He sees a physician or a nurse, who diagnoses him, usually......(read more)

July 19 - News, Stock Analysis - Comments

medicine, diabetes, glycemia, health care,patient, insulin-deficient, middle, app, measurement, male, disease, hypoglycemia, level, technology, medicine, mobile, checking, body, home, smartphone, hyperglycemia, stripe, part, health, indoors, man, glucometer, healthcare, test, human, diabetic, aged, medical, unhealthy, concept, gadget, ill, diabetes, sick, glucose, care, problem, person, cell, sugar, control, application, phone, blood, hand, insulin

The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All

At the turn of the millennium, the population of the United States clocked in at 282.2 million. By 2030, the US population is expected to be about 362......(read more)

June 22 - News, Stock Analysis - Comments

Pre-Market Primer: Why Investors Will be Watching Tesla, Merck, and Three Other Stocks Today

All three index futures are in the red in this morning’s pre-market as traders worry about a potential Brexit. While a Brexit wouldn’t be......(read more)

June 10 - Market Movers, News - Comments

17 Most Drug Addicted Countries in the World in 2017

Five Dividend Stocks Hedge Funds Love

Oil baron and America’s first billionaire John D. Rockefeller once said, ‘do you know the only thing that gives me pleasure? It’s to......(read more)

May 28 - Dividend Stocks, Hedge Funds, News - Comments

Kahn Brothers’ Top Stock Picks: Merck & Co. Inc. (MRK) Overtakes Citigroup Inc. (C) as Top Holding

Kahn Brothers Group is a New York-based hedge fund firm founded by Irving Kahn, Thomas Graham Kahn and Alan Kahn in 1978. Irving Kahn, the firm’s founding......(read more)

May 14 - Hedge Fund Analysis, Hedge Funds, News - Comments

accounting, desk, market, funds, economy, business, income, gains, value, wealth, revenue, pen, analysis, foreign, balanced, computer, management, graph, risk, equities, earnings, pie, chart, stocks, money, monetary, high, accountant, growth, low, invest, ratio, quotes, account, workplace, profits, trade, investment, return, office, banking, man, index, financial, hand, businessman, results, performance, exchange, capital

Why Merck, Whole Foods Market & Other Stocks Are in Spotlight Today?

The US Stock market is trading higher on Thursday, helped by a 3% growth in Brent and WTI. Meanwhile, the earnings season is still in progress and among......(read more)

May 5 - Hedge Funds, News - Comments

Five Healthcare Stocks Added to HealthInvest Partners’ Portfolio in Q1

HealthInvest Partners is a Stockholm-based fund management company founded by Carl Bennet and Anders Hallberg in 2006. The investment approach employed......(read more)

April 23 - Hedge Funds, News - Comments

Kahn Brothers’ Top Stock Picks for Early 2016; Citigroup Inc. (C) Leading the Pack

The Kahn Brothers Group, formerly known as Kahn Brothers & Company Inc., was founded in 1978 by renowned investor Irving Kahn, who died last year......(read more)

February 11 - Hedge Fund Analysis, Hedge Funds, News - Comments

Cisco Systems CSCO headquarters tech san jose networking corporation

Bourgeon Capital Loves These Five Stocks. Should You?

John A. Zaro, a Stanford graduate and a member of the New York Society of Security Analysts, founded Bourgeon Capital in 1999. Michael Keohane joined......(read more)

November 4 - Hedge Fund Analysis, Hedge Funds, News - Comments

computers, work,

Why Are These Five Stocks in Focus on Tuesday?

With the earnings season in progress, investors can take a step back from following macroeconomic news and focus on the financial results reported by......(read more)

October 27 - Earnings Report, Market Movers, News - Comments

Wall Street Stocks Market Insider Trading

Merck & Co., Inc. (MRK), Monster Beverage Corp (MNST) Jump On Analyst Upgrades

Shares of Merck & Co., Inc. (NYSE:MRK) and Monster Beverage Corp (NASDAQ:MNST) have both moved upward today thanks to bullish ratings updates by......(read more)

August 13 - Hedge Funds, News - Comments

Madison Street Partners Reshuffles Its Portfolio and Bets on ETFs; See Its Top Stock Picks

Steven Owsley‘s Madison Street Partners recently filed its 13F form for the second quarter with the SEC. There has been significant changes in......(read more)

August 3 - Hedge Funds, News - Comments